Skip to main content
. 2019 Jul 17;8(7):1042. doi: 10.3390/jcm8071042

Table 6.

Studies in patients with anorexia nervosa reporting clinical outcomes of the nutritional treatment.

Study Study Type Nº Patients Mean Age (years) Weight (kg) or BMI (kg/m2) at Admission Weight (kg) or BMI (kg/m2) at Discharge Length of Stay (days) Kcal/kg or kcal/day at Admission Type of Nutritional Treatment Outcome
Rigaud et al., 2007 [25] RCT
a: TF
b: control
a: 41
b: 40
a: 22.5
b: 24.2
a: 12.1
b: 12.8
a: 17.9
b: 15.9
60 a: 1000 (D0)–2450 (D14)
b: 1000 (D0)–1850 (D14)
a: OD + TF
b: OD
No RS
1-year relapse:
a: 44%
b: 52%
Diamanti et al., 2008 [44] Retrospective a: 104
b: 94
15 a: 36.3
b: 41
a: 39.6
b: 41.5
a: 30.7
b: 15.6
40 kcal/kg a: OD + PN
b: OD
No RS
a: Hypophosphataemia (6 cases),
Hypopotassaemia (3 cases)
Gentile et al., 2010 [26] Retrospective 33 22.8 11.3 13.5 60 1408 OD + TF + iv. glucose No RS
Vignaud et al., 2010 [33] Retrospective 68 31 12 - 7.6 (in ICU) 22.3 kcal/kg OD + TF + TPN RS (10%)
Mortality (10%)
Whitelaw et al., 2010 [34] Retrospective 29 15.7 72.9% IBW - - 1900–2200 (89% of patients) OD + ONS + TF (7 patients) Mild hypophosphataemia (37%)
Garber et al., 2012 [35] Prospective 35 16.2 16.3 - 17 1205 OD No RS
Hypophosphataemia (20%)
Gentile et al., 2012 [36] Retrospective 10 22 11.2 17.3 90 1199 OD + TF + iv. glucose No RS
Agostino et al., 2013 [37] Retrospective cohort study:
a: Nasogastric cohort
b: bolus-fed cohort
165 14.9 a: 16.6
b: 16.7
- a: 33.8
b: 50.9
a: 1617
b: 1069
a: 31 patients
b: 134 patients
No RS
a: Hypopotassaemia (1 case); readmissions at 6 months (12.9%)
b: Hypopotassaemia (1 case); mild-moderate hypophosphataemia (8 cases); readmissions at 6 months (23%)
Garber et al., 2013 [38] Prospective cohort:
a: high calorie
b: low calorie
56 16.2 a: 16.6
b: 15.8
- 14.9 a: 1700
b: 1093
OD + ONS No RS
Hypophosphataemia (45%)
Length of stay:
a: 11.9 days
b: 17.6 days
Golden et al., 2013 [39] Retrospective
a: low calorie
b: high calorie
a: 88
b: 222
16.1 a: 15.9
b: 16.1
a: 17.2
b: 17.1
a: 16.6
b: 13
a: 1163
b: 1557
OD + ONS + TF (occasionally) No RS
Hypophosphataemia (15.8%)
Hypomagnesaemia (15.2%)
Hypopotassaemia (20%)
Leclerc et al., 2013 [40] Retrospective 29 14.7 16.4 - 35.8 1500 OD + ONS Hypophosphataemia (3.5%)
Hofer et al., 2014 [27] Retrospective 65 27.9 13.7 15 49.5 10 kcal/kg OD (mostly)
OD + ONS (8.1%)
OD + TF (8.1%)
TF (5%)
OD + TPN (1.2%)
Mild RS (10.5%)
Severe hypopotassaemia (4.7%)
Brown et al., 2015 [28] Retrospective case-control 123 28 13 13.9 13 1200 OD Hypophosphataemia (33%)
O’Connor et al., 2016 [61] RCT
a: intervention
b: control
a: 18
b: 18
13.8 a: 32.4
b: 34.6
a: 34.1
b: 35.6
10 a: 38 kcal/kg/d
b: 16 kcal/kg/d
OD + TF a: Hypophosphataemia (28%)
b: Hypophosphataemia (11%)
Marugán et al., 2016 [29] Retrospective 50 14.5 15.45 17.58 44.54 1000 OD
ONS (16%)
TF (8%)
No symptoms of RS
Kameoka et al., 2016 [30] Retrospective 99 30.9 <17.5 - 82.7 Low calorie diet OD Hypophosphataemia (21.2%)
Smith et al., 2016 [62] Retrospective 129 15.8 15.8 17.1 14.9 1585 OD + ONS No RS
Hypophosphataemia (47.3%)
Hypokalaemia (12%)
Davies et al., 2017 [31] Retrospective 65 24 12.8 14.4 60 20-30 OD, ONS (infrequently) Mild hypophosphataemia (<0.8 mmol/L) (6.5%)
Hypokalaemia (1 case).
No RS
Peebles et al., 2017 [32] Retrospective 215 15.3 17.1 18.2 11 1466 OD, TF (10%) No RF.
Hypophosphataemia (14%)
3.8% and 17.2% rehospitalisations after 30 days and 1 year, respectively

TF: Tube Feeding, OR: Oral Diet, ONS: Oral Nutritional Supplements, RS: Refeeding Syndrome, PN: Parenteral Nutrition, TPN: Total Parenteral Nutrition, RCT: Randomised Controlled Trial.